Bondholders representing EUR 6.3 million of the outstanding loan of the EUR 375 million convertible bond issued by Marine Harvest ASA with ISIN NO 001 0710395, has in accordance with the bond agreement exercised the option to convert their bonds to equity at the conversion price of EUR 9.5273 per share. Marine Harvest ASA will satisfy the request by issuing 661,257 new shares, each with a nominal value of NOK 7.50. The new shares are expected to be issued on or about 14 February 2017.
Following the completion of the conversion, Marine Harvest ASA will have a share capital of NOK 3,392,173,823, divided into 452,289,843 total shares, each with a nominal value of NOK 7.50.
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.


Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



